The epithelial-mesenchymal transition of colon carcinoma involves expression of IL-8 and CXCR-1-mediated chemotaxis

Experimental Cell Research

Volumn 299, Issue 2, 2004, Pages 315-324

  Bates, Richard C ^a   Deleo III, Michael J ^a   Mercurio, Arthur M ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Autocrine signaling; Colon carcinoma; Cytokine; Interleukin 8; Migration; Tumor progression

Indexed keywords

ANTIBODY; CHEMOKINE; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CARCINOMA CELL; CHEMOTAXIS; COLON CARCINOMA; COLON MUCOSA; MESENCHYME; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; UPREGULATION;

EID: 4444319419     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2004.05.033     Document Type: Article

References (47)

1. Savagner P. Leaving the neighborhood: molecular mechanisms involved during the epithelial-mesenchymal transition. BioEssays. 23:2001;912-923
2. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev., Cancer. 2:2002;442-454
3. Arias A.M. Epithelial mesenchymal transitions in cancer and development. Cell. 105:2001;425-431
4. Bates R.C., Goldsmith J.D., Bachelder R.E., Brown C., Shibuya M., Oettegen P., Mercurio A.M. Flt-1-dependent survival characterizes the epithelial-mesenchymal transition of colonic organoids. Curr. Biol. 13:2003;1721-1727
5. Baggiolini M., Dewald B., Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55:1994;97-179
6. Mukaida N. Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am. J. Physiol.: Lung Cell. Mol. Physiol. 284:2003;L566-L577
7. Michel G., Kemeny L., Peter R.U., Beetz A., Ried C., Arenberger P., Ruzicka T. Interleukin-8-receptor mediated chemotaxis of human epidermal cells. FEBS Lett. 305:1992;241-243
8. Dunlevy J., Couchman J. Interleukin-8 induces motile behavior and loss of focal adhesions in primary fibroblasts. J. Cell Sci. 108:1995;311-321
9. Holmes W.E., Lee J., Kuang W.J., Rice G.C., Wood W.I. Structure and functional expression of a human interleukin-8 receptor. Science. 253:1991;1278-1280
10. Murphy P.M., Tiffany H.L. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science. 253:1991;1280-1283
11. Ahuja S.K., Murphy P.M. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRO beta, GRO gamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for type B, but no the type A, human interleukin-8 receptor. J. Biol. Chem. 271:1996;20545-20550
12. Lee J., Horuk R., Rice G.C., Bennett G.L., Camerato T., Wood W.I. Characterization of two high affinity human interleukin-8 receptors. J. Biol. Chem. 267:1992;16283-16287
13. Richardson R.M., Marjoram R.J., Barak L.S., Snyderman R. Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation and regulation. J. Immunol. 170:2003;2904-2911
14. Singh R.K., Gutman M., Radinsky R., Bucana C.D., Fidler I.L. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res. 54:1994;3242-3247
15. Ramjeesingh R., Leung R., Siu C. Interleukin-8 secreted by endothelial cells induces chemotaxis of melanoma cells through the chemokine receptor CXCR1. FASEB J. 17:2003;1292-1294
16. Heidemann J., Ogawa H., Dwinell M.B., Rafiee P., Maaser C., Gockel H.R., Otterson M.F., Ota D.M., Lugering N., Domschke W., Binion D.G. Angiogenic effects of interleukin 8 (CXCL8) in human microvascular endothelial cells are mediated by CXCR2. J. Biol. Chem. 278:2003;8508-8515
17. McLaughlan J.M., Seth R., Vautier G., Robins R.A., Scott B.B., Hawkey C.J., Jenkins D. Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation. J. Pathol. 18:1997;87-92
18. Arai F., Takahashi T., Furukawa K., Matushima K., Asakura H. Mucosal expression of interleukin-6 and interleukin-8 messenger RNA in ulcerative colitis and in Crohn's disease. Dig. Dis. Sci. 43:1998;2071-2079
19. Uguccioni M., Gionchetti P., Robbiani D.F., Rizzello F., Peruzzo S., Campieri M., Baggiolini M. Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am. J. Pathol. 155:1999;331-336
20. Williams E.J., Haque S., Banks C., Johnson P., Sarsfield P., Sheron N. Distribution of the interleukin-8 receptors, CXCR1 and CXCR2, in inflamed gut tissue. J. Pathol. 192:2000;533-539
21. Kido S., Kitadai Y., Hattori N., Haruma K., Kido T., Ohta M., Tanaka S., Yoshira M., Sumii M., Ohmoto Y., Chayama K. Interleukin 8 and vascular endothelial growth factor-prognostic factors in human gastric carcinomas? Eur. J. Cancer. 37:2001;1482-1487
22. Kitadai Y., Haruma K., Sumii K., Yamamoto S., Ue T., Yokozaki H., Yasui W., Ohmoto Y., Kajiyama G., Fidler I.J., Tahara E. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am. J. Pathol. 152:1998;93-100
23. Li A., Varney M.L., Singh R.K. Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials. Clin. Cancer Res. 7:2001;3298-3304
24. Haraguchi M., Komuta K., Akashi A., Matsuzaki S., Furui J., Kanematsu T. Occurrence of hematogenous metastasis and serum levels of thymidine phosphorylase in colorectal cancer. Oncol. Rep. 9:2002;159-165
25. Bates R.C., Mercurio A.M. Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol. Biol. Cell. 14:2003;1790-1800
26. Whitehead R.H., Jones J.K., Gabriel A., Lukies R.E. A new colon carcinoma cell line (LIM1863) that grows as organoids with spontaneous differentiation into crypt-like structures in vitro. Cancer Res. 47:1987;2683-2689
27. Bates R.C., Buret A., van Helden D.F., Horton M.A., Burns G.F. Apoptosis induced by inhibition of intercellular contact. J. Cell Biol. 125:1994;403-415
28. Wallach D., Varfolomeev E.E., Malinin N.L., Goltsev Y.V., Kovalenko A.V., Boldin M.P. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17:1999;331-367
29. Abreu-Martin M.T., Vidrich A., Lynch D.H., Targan S.R. Divergent action of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-alpha and ligation of Fas antigen. J. Immunol. 155:1995;4147-4154
30. Venkatakrishnan G., Salgia R., Groopman J.E. Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells. J. Biol. Chem. 275:2000;6868-6875
31. Mukaida N. Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int. J. Hematol. 72:2000;391-398
32. Kon A., Vindevoghel L., Kouba D.J., Fujimura Y., Uitto J., Mauviel A. Cooperation between SMAD and NF-kappaB in growth factor regulated type VII collagen gene expression. Oncogene. 18:1999;1837-1844
33. DiChiara M.R., Kiely J.M., Gimbrone M.A. Jr., Lee M., Perrella M.A., Topper J.M. Inhibition of E-selectin gene expression by transforming growth factor beta in endothelial cells involves coactivator integration of Smad and nuclear factor kappaB-mediated signals. J. Exp. Med. 192:2000;695-704
34. Papadakis K.A., Targan S.R. Tumor necrosis factor: biology and therapeutic inhibitors. Gastroenterology. 119:2000;1148-1157
35. Csiszar A., Szentes T., Haraszti B., Zou W., Emilie D., Petranyi G., Pocsik E. Charaterisation of cytokine mRNA expression in tumour-infiltrating mononuclear cells and tumour cells freshly isolated from human colorectal carcinomas. Eur. J. Cytokine Network. 12:2001;87-96
36. Naylor M.S., Stamp G.W., Foulkes W.D., Eccles D., Balkwill F.R. Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. J. Clin. Invest. 91:1993;2194-2206
37. Wu S., Boyer C.M., Whitaker R.S., Berchuck A., Wiener J.R., Weinberg J.B., Bast R.C. Jr. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression. Cancer Res. 53:1993;1939-1944
38. Takanami I., Takeuchi K., Kodaira S. Tumor-associated macrophage infiltration in pulmonary adenocarcinoma: association with angiogenesis and poor prognosis. Oncology. 57:1999;138-142
39. Chen J.J.W., Yao P.L., Yuan A., Hong T.M., Shun C.T., Kuo M.L., Lee Y.C., Yang P.C. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Clin. Cancer Res. 9:2003;729-737
40. Chuntharapai A., Kim J. Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor. J. Immunol. 155:1995;2587-2594
41. Quan J., Martin T., Foster D.C., Whitmore T., Goodman R.B. Antibodies against the N-terminus of IL-8 receptor A inhibit neutrophil chemotaxis. Biochem. Biophys. Res. Commun. 219:1996;405-411
42. Brew R., Erikson J.S., West D.C., Kinsella A.R., Christmas S.E. Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine. 12:2000;78-85
43. Richardson R.M., DuBose R.A., Ali H., Tomhave E., Haribabu B., Snyderman R. Regulation of human interleukin-8 receptor A: identification of a phosphorylation site involved in modulating receptor functions. Biochemistry. 34:1995;14193-14201
44. Mueller S.G., White J.R., Schraw W.P., Lam V., Richmond A. Ligand-induced desensitization of the human CXC chemokine receptor-2 is modulated by multiple serine residues in the carboxyl-terminal domain of the receptor. J. Biol. Chem. 272:1997;8207-8214
45. Feniger-Barish R., Ran M., Zaslaver A., Ben-Baruch A. Differential modes of regulation of CXC chemokine-induced internalization and recycling of human CXCR1 and CXCR2. Cytokine. 11:1999;966-1009
46. Zaslaver A., Feniger-Barish R., Ben-Baruch A. Actin filaments are involved in the trafficking of two closely related chemokine receptors, CXCR1 and CXCR2. J. Immunol. 166:2001;1272-1284
47. Addison C.L., Daniel T.O., Burdick M.D., Liu H., Ehlert J.E., Xue Y.Y., Beuchi L., Walz A., Richmond A., Strieter R.M. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR + CXC chemokine-induced angiogenic activity. J. Immunol. 165:2000;5269-5277